Sheng-Xian-Tang alleviates endoplasmic reticulum stress, autophagy, and apoptosis through the PI3K/AKT/mTOR pathway in pulmonary fibrosis
Quan Ma, Hong Yang, Zhongbo Zhu, Caifeng Luo, Yanlin Wu, Xuhui Zhang, Xiping Liu
Gansu University of Traditional Chinese Medicine
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Background Pulmonary fibrosis (PF) is a progressive interstitial lung disease with high morbidity and mortality. Sheng-Xian-Tang (SXT) has shown therapeutic potential against PF. This study aimed to elucidate the underlying mechanisms of SXT in PF. Methods A bleomycin-induced PF rat model was established, and SXT-containing serum was prepared. Chemical constituents were identified using ultra-high performance liquid chromatography coupled with high-resolution mass spectrometry (UPLC-HRMS). A549 cells were exposed to bleomycin with or without SXT-containing serum or pirfenidone (positive control). Fibrosis markers, apoptosis, ultrastructural changes, as well as proteins related to endoplasmic reticulum (ER) stress, autophagy, and apoptosis, were evaluated using ELISA, flow cytometry, transmission electron microscopy, and Western blotting. The PI3K/AKT/mTOR pathway was assessed following treatment with inavolisib, a PI3K inhibitor. Results UPLC-HRMS identified five SXT-derived compounds in rat serum, including neomangiferin, isomangiferin, timosaponin B II, timosaponin A III, and (R)-2-hydroxystearate. In bleomycin-treated A549 cells, both SXT-containing serum and pirfenidone significantly reduced TGF-β1 and α-SMA levels. Moreover, they alleviated ER dilation and reduced autophagosome and apoptotic body formation. These effects were accompanied by the downregulation of XBP1, GRP78, CHOP, LC3β, caspase-12, caspase-3, and Bax, and the upregulation of p62 and Bcl-2. Furthermore, bleomycin-induced activation of the PI3K/AKT/mTOR pathway was markedly suppressed by SXT and inavolisib. Conclusion SXT alleviates PF by attenuating ER stress and its downstream autophagy and apoptosis, potentially via inhibition of the PI3K/AKT/mTOR pathway. This study provides insight into the bioactive constituents of SXT, supporting its potential application in PF therapy. However, the findings are primarily based on in vitro experiments, and further in vivo validation is required to confirm the mechanisms.
逐年被引趋势
暂无年度引用数据
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Endoplasmic Reticulum Stress and Disease · Pulmonary Hypertension Research and Treatments